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Tbjective: This study compares clinical results of the standard Maze III operation,
highly effective treatment for atrial fibrillation, to less complex variations of the
aze III operation utilizing unipolar and bipolar radiofrequency ablation and
ulmonary vein isolation.
ethods: Records were reviewed of 377 patients who had operations for treatment
f atrial fibrillation at a single institution over a 10-year period. Standard Maze III
as performed in 220 patients, unipolar radiofrequency Maze III in 60, bipolar
adiofrequency Maze III in 65, and radiofrequency pulmonary vein isolation in
2. Electrocardiograms were obtained at discharge and 3-, 6-, and 12-month
ntervals. Chi-square test, logistic regression, and Bayesian theory analyses were
erformed to determine significant associations between operative procedures
nd outcomes.
esults: Mean age was 65.1 years (range 22-87). There were 13 hospital deaths
3.4%) and 16 deaths during follow-up. Most patients (90.2%, 340/377) had con-
omitant operations. Electrocardiogram analysis was available in 344 patients at 3
onths and 313 patients at 6 months. Freedom from atrial fibrillation at 6 months
as superior after standard Maze III compared with radiofrequency modifications.
ubanalysis according to surgeon experience demonstrated good results regardless
f operative experience.
onclusions: This single-institution experience suggests that the standard Maze III
peration is superior to radiofrequency operations for treatment of atrial fibrillation.
adiofrequency modifications of the Maze III operation are also effective treatments
or atrial fibrillation and can achieve good results regardless of surgeon experience.
trial fibrillation affects approximately 1% of the population of the United
States and is a major risk factor for the development of stroke, permanent
disability, and death.1,2 Over 2 million individuals in the United States
ore than 5 million worldwide are estimated to have this disease.3 A surgical
pproach to cure atrial fibrillation was pioneered and refined by Cox and associ-
tes.4,5 Although technically challenging, the Maze III operation has been de
trated to be highly effective in restoring a regular rhythm in patients, both for
solated atrial fibrillation and in association with mitral valve disease.6-9
Recently, multiple devices have been developed that may potentially provide
ew methods for performing the Maze III operation. Rather than requiring the
urgeon to make multiple incisions on the atria, these devices employ various
odalities such as radiofrequency (RF), microwave, laser, or cryoablation energy to
reate a linear path of injury to the atrial wall. The injury results in scar formation,
esulting in the eventual Maze III pathway without the extensive “cut and sew”
ncisions from the standard Maze III operation. Early results suggest that these
evices are effective and can make the operation easier, more efficient, and safer,
he Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 4 1037
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A
CDllowing more surgeons to offer this potentially curative
urgery to more patients.10-21
This study examines the efficacy of devices employing
F energy to perform modified versions of the Maze III
peration in comparison with the standard “cut and sew”
aze III operation. This study was performed at a single
nstitution (LDS Hospital, Salt Lake City, Utah) by a single
roup of surgeons. The primary end point for analysis and
valuation was the percentage of patients who are free from
trial fibrillation 6 months after surgery.
aterials and Methods
ata Collection
retrospective analysis was performed of all patients in the LDS
ospital surgical database who had an operation for atrial fibril-
ation. Over a 10-year period, 377 patients underwent surgery for
trial fibrillation, with or without a concomitant operation. Peri-
perative data collected included date of surgery, operating sur-
eon, type of operation, gender, age, atrial fibrillation history,
ardioversion history, concomitant operation, and rhythm at dis-
harge from the hospital. Follow-up data collected included
hythm at 3 months, 6 months, and then yearly; antiarrhythmic
herapy at 3 months, 6 months, and then yearly; and anticoagulant
edication.
Preoperative rhythm was categorized as either intermittent or
ontinuous atrial fibrillation according to the classification by
ox.22 Patients were stratified into 2 major groups for free
rom atrial fibrillation after operation. Patients in sinus rhythm,
aced rhythm, junctional rhythm, or other regular rhythm were
onsidered to be free from atrial fibrillation. Patients with atrial
brillation, atrial flutter, or other irregular rhythm were considered
o be failures of surgical therapy.
perative Techniques
Standard Maze III operation. The surgical technique for the
tandard Maze III operation has been previously described.4 Sur-
ical incisions were made without variation from the original
echnique, and 70°C cryoablation lesions were placed on the
oronary sinus, the posterior mitral annulus, and two sites on the
ricuspid valve annulus. The right atrial incisions were performed
rior to aortic occlusion and arrest of the heart via cold retrograde
lood cardioplegia for the left atrial incisions.
Unipolar RF Maze III modification. The surgical technique
or the modification of the Maze III operation using a unipolar RF
evice is illustrated in Figure 1. The Medtronic Cardioblate
ated unipolar RF system (Medtronic, Inc, Minneapolis, Minn)
as used for all patients having this operation. The left atrial
ppendage was excised, and atrial incisions were limited to an
blique incision on the right atrium, a vertical incision in the right
trial appendage, and a standard left atriotomy. The remainder of
he Maze III lesions were created on the endocardial surface using
Abbreviations and Acronyms
RF radiofrequencyhe unipolar pen. No cryoablation was employed. c
038 The Journal of Thoracic and Cardiovascular Surgery ● AprBipolar RF Maze III modification. The surgical technique for
he modification of the Maze III operation using a bipolar RF
evice is illustrated in Figure 2. Two devices were use
atients having this operation: the Medtronic Cardioblate BP irri-
ated bipolar RF system (Medtronic, Inc) and the AtriCure non-
rrigated bipolar RF system (AtriCure, Inc, Cincinnati, Ohio). As
ith the unipolar modification, the left atrial appendage was ex-
ised, and atrial incisions were limited to an oblique incision on the
ight atrium, a vertical incision in the right atrial appendage, and a
tandard left atriotomy. The remainder of the Maze III lesions were
reated by clamping the atrial wall between the electrodes of the
ipolar device. In areas where the bipolar device could not be
laced across the atrial wall, such as the atrial septum, the coronary
inus, or near the mitral and tricuspid annulus, either the unipolar
F pen or 70°C cryoablation lesions were used to complete the
esions. Right atrial inferior isthmus ablation was performed when
ardioblate BP was employed but not with AtriCure.
RF pulmonary vein isolation. The surgical technique for pul-
onary vein isolation using a bipolar RF device is illustrated in
igure 3. Two devices were used for patients having this oper
he Medtronic Cardioblate BP irrigated bipolar RF system
Medtronic, Inc) and the AtriCure nonirrigated bipolar RF system
AtriCure, Inc). The left atrial appendage was excised to remove a
otential source of embolization. The right and left pulmonary
eins were dissected free, and an RF lesion was created by placing
arm of the device on the left atrial wall behind the pulmonary
eins and 1 arm on the atrial wall in front of the pulmonary veins.
connecting lesion between the left atrial appendage and the left
ulmonary vein encircling lesion completed the procedure. No
igure 1. Unipolar RF modification of Maze III operation. The left
trial appendage is excised, and atrial incisions are limited to an
blique incision on the right atrium, a vertical incision in the right
trial appendage, and a standard left atriotomy. The remainder of
he Maze III lesions are created on the endocardial surface using
he unipolar pen. RF, radiofrequency.ryoablation was employed.
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CDoncomitant Operations
dditional procedures, such as cardiac valve operations, coronary
rtery bypass, aortic root replacement, and reconstruction of the
scending aorta, were performed as indicated. Portions of these
perations and the Maze III operations were done in a logical
equence during surgery.
ostoperative Management
ostoperative intensive care and general recovery care were
dministered in identical fashion to standard care for patients
ecovering from cardiac surgery. Temporary pacing wires were
laced on all patients and used as indicated. Antiarrhythmic
edications and anticoagulants were not routinely used. Such
edications were employed with recurrence of atrial fibrillation
r in the setting of mechanical valve prostheses or multiple
alve replacement.
tatistical Analysis
hi-square tests were performed to test the null hypothesis that
igure 2. Bipolar RF modification of the Maze III operation. As
ith the unipolar modification, the left atrial appendage is ex-
ised, and atrial incisions are limited to an oblique incision on
he right atrium, a vertical incision in the right atrial appendage,
nd a standard left atriotomy. The remainder of the Maze III
esions are created by clamping the bipolar device across the
trial wall. In areas where the bipolar device cannot be placed
cross the atrial wall, such as the atrial septum or near the mitral
nd tricuspid annulus, either the unipolar pen or 70°C cryoab-
ation lesions are used to complete the lesions. RF,
adiofrequency.reedom from atrial fibrillation rates were the same among proce- a
The Journal of Thoracicures. Multiple logistic regression analysis was performed to con-
rol for additional factors that were also associated with freedom
rom atrial fibrillation. Odds ratios of the various RF Maze pro-
edures compared with the standard procedure are reported along
ith their 95% confidence intervals. Bayesian multiple logistic
egression using the Metropolis–Hastings Algorithm was also em-
loyed using 100,000 iterations. For the Bayesian analysis, each
ogistic regression coefficient was initially assumed to be distrib-
ted normal with mean 0, and standard deviation was set to 0.2.
he Bayesian analysis generated the probability distribution for
he freedom from atrial fibrillation rate for each procedure and
rovided greater confidence in analysis where numbers of data
oints were small. Overlapping distributions support the conclu-
ion that freedom from atrial fibrillation rate was not different
igure 3. RF pulmonary vein isolation. The left atrial appendage
s excised to remove a potential source of embolization. The right
nd left pulmonary veins are dissected free, and an RF lesion is
reated by placing 1 arm of the device on the atrial wall behind
he pulmonary veins and 1 arm on the atrial wall in front of the
ulmonary veins. A connecting lesion between the left atrial
ppendage and the left pulmonary vein encircling lesion com-
letes the procedure. RF, radiofrequency.mong the procedures.
and Cardiovascular Surgery ● Volume 133, Number 4 1039
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A
CDesults
hree hundred seventy-seven patients had surgery for atrial
brillation over a 10-year period; mean age was 65.1 years
range 22-87). There were 200 male and 177 female pa-
ients. Standard Maze III operation was performed in 220
atients, unipolar RF Maze III in 60, bipolar RF Maze III in
5, and RF pulmonary vein isolation in 32. Most patients
90.2%, 340/377) had concomitant operations, most com-
only isolated or multiple valve procedure (52.8%), com-
ined coronary artery bypass and valve procedure (19.1%),
r isolated coronary artery bypass (7.2%); 32 patients
eeded reoperation (8.5%). Preoperative data are summa-
ized in Table 1.
The indication for Maze III operation was continuous
trial fibrillation in 64.5% (n  243) and intermittent atrial
brillation in 35.5% (n  134). In the standard Maze III
roup, indication for surgery was continuous atrial fibrilla-
ion in 65.9% (n 145) and intermittent atrial fibrillation in
4.1% (n  75). In the unipolar RF Maze III group, indi-
ation for surgery was continuous atrial fibrillation in 75.0%
n  45) and intermittent atrial fibrillation in 25.0% (n 
5). In the bipolar RF Maze III group, indication for surgery
as continuous atrial fibrillation in 67.7% (n  44) and
ntermittent atrial fibrillation in 32.3% (n  21). In the RF
ulmonary vein isolation group, indication for surgery was
ontinuous atrial fibrillation in 28.1% (n  9) and intermit-
ent atrial fibrillation in 71.9% (n  23). Slightly less than
ABLE 1. Summary of patient demographics and preopera
Standard Maze III Unip
220
ender 120 M
100 F
ean age, y (range) 62.5 (31-82)
trial fibrillation history
Continuous 145
Intermittent 75
ardioversion history
Percutaneous ablation 17
Chemical cardioversion 21
Electrical cardioversion 23
Chemical  electrical 24
oncomitant operation
MVR 27
Mitral valve repair 17
MVR  tricuspid valve repair 12
Mitral repair  tricuspid repair 21
CAB 12
CAB  valve operation 32
Other 64
eoperation 11
F, Radiofrequency; MVR, mitral valve replacement; CAB, coronary arteryalf (42.2%) of patients had had no attempt at cardioversion 2
040 The Journal of Thoracic and Cardiovascular Surgery ● Aprrior to surgery. Only 29 (7.7%) had previously had suc-
essful cardioversion to sinus rhythm prior to surgery; the
emainder had various unsuccessful electrical, chemical,
nd percutaneous ablative attempts at cardioversion.
There were 13 hospital deaths (3.4%): 3 in the standard
aze III group (1.5%), 4 in the unipolar RF Maze III group
5.0%), 1 in the bipolar RF Maze III group (1.5%), and 5 in
he RF pulmonary vein isolation group (15.6%). Causes of
eath included cardiac failure in 5, multisystem organ fail-
re in 3, respiratory failure in 2, sepsis in 2, and ischemic
owel in 1. There was no statistical difference in hospital
ortality among the groups.
Stroke or other neurologic event occurred in 3 patients: 1
atient in the standard Maze group and 2 in the bipolar RF
odification group. All 3 patients died as a result of the
erebrovascular event. The patient in the standard Maze group
ad a massive embolic stroke 3 weeks after concomitant aortic
alve replacement with a porcine bioprosthesis, mitral valve
nuloplasty, and coronary artery bypass grafting. This patient
as in sinus rhythm and was adequately anticoagulated on oral
arfarin therapy at the time of the stroke. The first patient in
he bipolar RF group suffered an intraoperative stroke during a
hird reoperation for concomitant mitral valve replacement
ith a mechanical prosthesis and coronary artery bypass graft-
ng. This patient had some recovery but died 5 months after
urgery from complications related to neurologic impairment.
he second patient in the bipolar RF group became comatose
variables
RF Maze III Bipolar RF Maze III RF pulmonary vein isolation
60 65 32
M
F
35 M
30 F
14 M
18 F
(38-87) 67.3 (43-85) 70.5 (22-87)
5 44 9
5 21 23
1 4 1
5 10 8
4 6 0
12 3 3
4 7 2
5 9 3
0 4 0
6 7 0
5 2 7
15 20 10
24 15 10
3 6 6
ss.tive
olar
31
29
69.3
4
1
1weeks after a third reoperation for concomitant aortic valve
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CDeplacement and mitral valve replacement with bioprostheses,
oronary artery bypass grafting, and tricuspid anuloplasty. This
atient remained in atrial fibrillation after surgery and was
nticoagulated on intravenous heparin. Imaging studies were
onsistent with brain stem demyelination, and support was
ithdrawn.
Eight patients were lost to follow-up; follow-up was 98%
omplete. Mean length of follow-up was 23 months (range
days to 119 months). Permanent pacemaker implantation
as required in 39 (10.3%) patients. Pacemaker implanta-
ion was most common in the bipolar RF Maze III group
20.0%) and least common in the RF pulmonary vein iso-
ation group (6.3%). Requirement for permanent pacemaker
mplantation was similar for the standard Maze III group
8.1%) and the unipolar RF Maze III group (10.0%).
There were 16 additional deaths during follow-up: 4 in the
tandard Maze III group, 6 in the unipolar RF Maze III group,
in the bipolar RF Maze III group, and 3 in the RF pulmonary
ein isolation group. Cause of late death was not possible to
etermine reliably from death certificate information.
Electrocardiogram analysis was available in 344 patients
t 3 months and 313 patients at 6 months (Table 2).
ard chi-square test and pairwise comparisons without re-
ard for confounding variables were first performed to
etermine significant associations between operative proce-
ures and outcomes. Freedom from atrial fibrillation at 3
onths was better after standard Maze III compared with
ther procedures (P  .0001). At 6 months, freedom from
trial fibrillation remained superior after standard Maze III
ompared with other procedures (P  .0078).
Multiple logistic regression controlling for confounding
ariables was then performed on the data for the entire patient
ohort to identify variables affecting outcomes after each form
f the Maze III operation (Table 3). After controlling
ABLE 2. Summary of 3-month and 6-month freedom from
Standard Maze III, n (%) Unipolar RF Maze III, n (%)
ime
3 mo 190/210 (90.5) 33/50 (66.0)
6 mo 175/194 (90.2) 33/46 (71.7)
F, radiofrequency.
ABLE 3. Summary of logistic regression analysis of free-
om from atrial fibrillation at 6 months according to pro-
edure, as compared to standard Maze III operation
Odds
ratio P
95% confidence
interval
nipolar RF Maze III 0.28 .0001 0.12-0.61
ipolar RF Maze III 0.42 .047 0.19-0.96
ulmonary vein isolation 0.58 .559 0.15-2.17F, radiofrequency. R
The Journal of Thoracicn-
r
onfounding variables, freedom from atrial fibrillation after the
tandard Maze III operation was statistically superior to unipo-
ar RF Maze III and bipolar RF Maze III operations. Freedom
rom atrial fibrillation after RF pulmonary vein isolation
as statistically equivalent to standard Maze III opera-
ion. There was no statistical difference among the 3 RF
odifications of the Maze III operation.
Further exploration of the variables was performed using
ayesian theory. Subanalysis was performed according to
perating surgeon, identified by number. Figure 4 illustr
he distribution of procedures by each surgeon. Surgeon #1
ad the most experience with unipolar RF Maze III. Sur-
eon #2 had the most experience with the standard Maze III
peration, bipolar RF Maze III, and RF pulmonary vein
solation. Figure 5 illustrates the probability distribution
reedom from atrial fibrillation rate for each procedure. The
tandard Maze III operation has the best freedom from atrial
brillation, but the probability distributions overlap for all
f the procedures. Figure 6 illustrates surgeon #2’s 
omes for freedom from atrial fibrillation in patients under-
oing surgery for atrial fibrillation. Again, freedom from
trial fibrillation was best with the standard Maze III oper-
tion in this surgeon’s experience, but the probability dis-
ributions overlap for all of the procedures. Figure 7 
rates the combined outcomes of the other surgeons with
ess experience in patients having surgery for atrial fibril-
ation. Freedom from atrial fibrillation was also superior in
hese surgeons’ experience with the standard Maze III op-
l fibrillation according to operative technique
olar RF Maze III, n (%) RF pulmonary vein isolation (n) P
32/59 (54.2) 18/25 .0001
43/54 (79.6) 16/19 .0078
igure 4. Distribution of procedures according to operating surgeon.atria
BipF, radiofrequency.
and Cardiovascular Surgery ● Volume 133, Number 4 1041
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A
CDration, and the probability distributions overlap. Regard-
ess of type of operation or surgeon experience, freedom
rom atrial fibrillation after any form of RF operations was
ot different from standard Maze III operation.
igure 5. Bayesian analysis for probability of freedom from atrial
brillation for all surgeons by operation at 100,000 iterations.
tandard Maze III operation has the greatest freedom from atrial
brillation but is not statistically different from RF modifications.
F, radiofrequency.
igure 6. Bayesian analysis for probability of freedom from atrial
brillation for the single most experienced surgeon by operation
t 100,000 iterations. Standard Maze III operation has the greatest
reedom from atrial fibrillation but is not statistically differentprom RF modifications. RF, radiofrequency.
042 The Journal of Thoracic and Cardiovascular Surgery ● AprInformation on antiarrhythmic therapy was available for
63 patients. Antiarrhythmic therapy was determined by
ach patient’s internist or cardiologist, was variable accord-
ng to individual physician practice, and could be unrelated
o presence or absence of atrial fibrillation. The majority of
hese patients (219, 83.3%) were taking no antiarrhythmic
edications. Most of the remaining patients (29, 11.0%)
ere maintained on amiodarone.
Information on anticoagulation therapy was available for
84 patients. Anticoagulation was determined by each pa-
ient’s internist or cardiologist, was variable according to
ndividual physician practice, and could be unrelated to
resence or absence of atrial fibrillation. Of these patients,
6 (30.1%) were on no anticoagulation, 106 (37.3%) were
n aspirin only, and 92 (32.4%) were on warfarin therapy.
iscussion
he Maze III operation has become the standard surgical
pproach for the treatment of atrial fibrillation, with low
ortality and cure rates approaching 90% of patients in
inus rhythm as reported by multiple authors.6-9 Despite
hese excellent results, the “cut and sew” Maze III operation
as not been widely adopted. The operation is technically
hallenging and time-consuming, and many surgeons are
eluctant to add such a lengthy procedure to operations that
ay already include valve and/or coronary artery bypass
igure 7. Bayesian analysis for probability of freedom from atrial
brillation for all other surgeons by operation at 100,000 iterations.
tandard Maze III operation has the greatest freedom from atrial
brillation but is not statistically different from RF modifications. RF,
adiofrequency.rocedures. In addition, the general perception of the med-
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A
CDcal community is that atrial fibrillation is not a particularly
angerous condition and can be safely managed with anti-
oagulation and cardiac rate control rather than subject a
atient to an additional procedure during cardiac surgery.
This study demonstrates that RF modifications of the
aze III operation can be performed with equivalent mor-
ality to the standard Maze III operation. More importantly,
hese modified operations produce high cure rates for atrial
brillation. Other investigators have previously reported
ood success rates with unipolar endocardial or epicardial
F ablation techniques.23-25 Although there was no stati-
ically significant difference between the 3 types of RF
perations in this study, the bipolar RF Maze III operation
ad the highest freedom from atrial fibrillation. This rate
as essentially identical to that of the standard Maze III
peration and is similar to that reported by Gillinov and
olleagues.26 It is important to note that RF modification
he Maze III operation will typically not result in immediate
estoration of sinus rhythm, or even within short-term
ollow-up.15 As demonstrated by this series of patie
owever, the full effect of RF Maze III surgery can be
eliably measured at the 6-month interval, when full devel-
pment of atrial scar has occurred.
Bipolar RF ablation should result in the most thorough
inear scar, as transmurality of the lesion is assured when
here is loss of conduction across the atrial tissue. Unipolar
F ablation, although effective in this cohort of patients,
robably is less effective at producing a transmural lesion,
articularly in thick atrial tissue.27 It is our preference 
eserve use of unipolar RF ablation for the isolated portions
f the Maze III operation where the bipolar device cannot be
pplied safely or effectively, including the atrial septum,
here fat in the intra-atrial groove impedes transmission of
nergy and where care must be taken to avoid injuring the
alve leaflet tissue near the mitral and tricuspid annuli, and
hen crossing the left atrial isthmus to prevent injury to the
oronary sinus or the left circumflex coronary artery. In all
hese locations, the atrial wall is thin and transmural abla-
ion can be safely accomplished using unipolar application
f energy. Unipolar RF ablation is also useful in the setting
f reoperation where complete dissection of the heart is
ither impossible or risky due to extensive adhesions.
RF pulmonary vein isolation has recently been described
s an effective modality for treatment of atrial fibrillation
nd was confirmed in this study as well.28,29 However, the
umber of patients having pulmonary vein isolation was
elatively small compared with the other 3 groups of pa-
ients and had a higher percentage of patients with intermit-
ent atrial fibrillation. We do not recommend employing
ulmonary vein isolation as the sole treatment of atrial arrhyth-
ias, except in patients with paroxysmal/intermittent atrial
brillation where probability of trigger sites located in the
ulmonary veins is high. Pulmonary vein isolation does not
The Journal of Thoracicreat trigger sites located in areas of the atria or septum,
esulting in right-sided atrial arrhythmias, including atrial
utter, which most commonly originates from the right
trial isthmus.30 Again, the higher mortality in this group
atients should be considered in light of the relatively small
umber of patients in this particular series.
Control of operative technique is nearly impossible in
ny clinical series. Operations tend to evolve somewhat
ver time, and ability to perform the operation generally
mproves with experience. Of particular interest in this
tudy, therefore, is the comparison of outcomes between the
urgeon with the most experience and those with less ex-
erience in arrhythmia surgery. All surgeons were able to
btain good results with all forms of the Maze III operation,
nd the curves for the RF modifications are essentially
dentical for the surgeon with the most experience and the
urgeons with less experience. This suggests that good
esults with the RF Maze III operations can be obtained by
ost surgeons, regardless of previous experience with the
tandard “cut and sew” Maze III operation.
The current study has several limitations that should be
onsidered. First, recurrence of atrial fibrillation may occur
t intervals between clinical follow-up and may not be
dentified with surveillance electrocardiography. The true
ncidence of recurrence of atrial fibrillation in this patient
ohort may therefore be underestimated. Second, the exact
ause of recurrence of atrial fibrillation in each patient is not
nown, as few patients had postoperative electrophysiologic
valuation. Without such evaluation, the source and location
f such failures, such as conduction gap or failed interrup-
ion of reentry, is unknown. Last, postoperative antiarrhyth-
ic therapy was not standardized but rather variable ac-
ording to individual surgeon and referring physician
ractice. Such variability does not allow for adequate anal-
sis of true freedom from atrial fibrillation without the use
f antiarrhythmic therapy.
In conclusion, analysis of this series of patients demon-
trates that RF modifications of the Maze III operation can
e performed with equivalent mortality and success in cur-
ng atrial fibrillation when compared with standard Maze III
peration. The RF modifications achieve a Maze III opera-
ion efficiently and safely, regardless of an individual sur-
eon’s prior experience with the standard Maze III opera-
ion. The RF operations allow more surgeons to apply this
echnology to a broader range of patients, thereby offering
reatment to a greater number of individuals with atrial
brillation.
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